To estimate the prevalence of preventable drug-related hospital admissions (PDRAs) and to explore if selected study characteristics affect prevalence estimates.
METHODS:
Keyword search of MEDLINE (1966–December 1999), International Pharmaceutical Abstracts (1970–December 1999), and hand search. Two reviewers independently selected studies published in peer-reviewed journals and extracted crude prevalence estimates and study characteristics. Trials had to specifically address consequences of drug therapy requiring hospital admission and include a quantitative preventability assessment. Stratified analysis and meta-regression were used to explore the association between study characteristics and prevalence estimates.
DATA SYNTHESIS:
Fifteen studies reported a median PDRA prevalence of 4.3% (interquartile range [IQR] 3.1–9.5%). The median preventability rate of drug-related admissions was 59% (IQR 50–73%). No evidence of publication bias related to study size could be determined. Because the individual study results were highly heterogeneous (Cochran's Q = 176, df = 14; p < 0.001), no meta-analytic summary estimate was computed. Stratified analysis suggested an association between prevalence estimates and 3 study characteristics: exclusion of first admissions (readmission studies: average PDRA prevalence of 14.0 %, estimated prevalence OR = 3.7); mean age of admissions >70 (OR = 2.1); and inclusion of “indirect” drug-related morbidity, such as omission errors or therapeutic failure (OR = 1.9). There was little evidence of other associations with prevalence estimates, such as selection of specific hospital units, exclusion/inclusion of planned admissions, country, and specified methods of PDRA case ascertainment.
CONCLUSIONS:
Drug-related morbidity is a significant healthcare problem, and a great proportion is preventable. Study methods in prevalence reports vary and should be considered when interpreting findings or planning future research.
Committee on Quality of Health Care in America, Institute of Medicine: to err is human—building a safer health system. Washington, DC: National Academy Press, 1999.
2.
BrennanTA. The Institute of Medicine report on medical errors—could it do harm?Tex Med2000;96: 13–5.
3.
McDonaldCJWeinerMHuiSL. Deaths due to medical errors are exaggerated in Institute of Medicine Report. JAMA2000;284: 93–5.
4.
LeapeLL. Institute of Medicine medical error figures are not exaggerated. JAMA2000;284: 95–7.
5.
SoxHCJr.WoloshinS. How many deaths are due to medical error? Getting the number right. Eff Clin Pract2000;3: 277–89.
6.
HaywardRAHoferTP. Estimating hospital deaths due to medical errors: Preventability is in the eye of the reviewer. JAMA2001;286: 415–20.
7.
DarchyBLe MiereEFigueredoBBavouxEDomartY. Iatrogenic diseases as a reason for admission to the intensive care unit: Incidence, causes, and consequences. Arch Intern Med1999;159: 71–8.
8.
NgDGoshDGHarrisJWhiteheadC. Unplanned medication-related admissions to an acute care general teaching hospital. Aust J Hosp Pharm1999;29: 84–7.
9.
RaschettiRMennitiIFMorguttiMBelisariARossignoliA. Adverse drug events in hospitalized patients. JAMA1997;277: 1351–2.
10.
CunninghamGDoddTRPGrantDJMcMurdoMETRichardsRME. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing1997;26: 375–82.
CourtmanBJStallingsSB. Characterization of drug-related problems in elderly patients on admissions to a medical ward. Can J Hosp Pharm1995;48: 161–6.
13.
DartnellJGAAndersonRPChohanVGalbraithKJLyonMENestorPJHospitalisation for adverse events related to drug therapy: Incidence, avoidability, and costs. Med J Aust1996;164: 659–62.
14.
HallasJGramLFGrodumEDamsboNBrosenKHaghfeltTDrug-related admissions to medical wards: A population-based survey. Br J Clin Pharmacol1992;33: 61–8.
15.
LindleyCMTullyMPParamsothyVTallisRC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing1992;21: 294–300.
16.
NikolausTLeibleSpecht NKruseWHHOsterPSchlierfG. [The early rehospitalization of elderly patients. Causes and prevention]. German. Dtsch Med Wochenschr1992;117: 403–7.
17.
BeroLALiptonHLBirdJA. Characterization of geriatric drug-related hospital readmissions. Med Care1991;29: 989–1003.
18.
BigbyJDunnJGoldmanLAdamsJBJenPLandefeldCSAssessing the preventability of emergency hospital admissions. A method for evaluating the quality of medical care in a primary care facility. Am J Med1987;83: 1031–6.
TrunetPBordaITRougetA-VRapinMLhosteF. The role of drug-induced illness in admissions to an intensive care unit. Intensive Care Med1986;12: 43–6.
21.
TrunetPLe GallJRLhosteFRegnierBSaillardYCarletJThe role of iatrogenic disease in admissions to intensive care. JAMA1980;244: 2617–20.
22.
KarchFELasagnaL. Adverse drug reactions. JAMA1975;234: 1236–41.
23.
HallasJHarvaldBGramLFGrodumEBrosenKHaghfeltTDrug related hospital admissions: The role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med1990;228: 83–90.
24.
NaranjoCABustoUSellersEMSandorPRuizIRobertsEAA method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981;30: 239–45.
25.
KramerMSLeventhalJMHutchinsonTAFeinsteinAR. An algorithm for the operational assessment of adverse drug reactions. I. Background, description and instructions for use. JAMA1979;242: 623–32.
26.
AshtonCMKuykendallDHJohnsonMLWrayNP. An empirical assessment of the validity of explicit and implicit process-of-care criteria for quality assessment. Med Care1999;37: 798–808.
27.
ShadishWRHaddockCK. Combining estimates of effect size. In: CooperHHedgesLV, eds. The handbook of research synthesis. New York: Russel Sage Foundation, 1994:266.
28.
GreenlandSRothmanKJ. Introduction to categorical statistics. In: RothmanKJGreenlandS, eds. Modern epidemiology. Philadelphia: Lippincott-Raven, 1998: 240–1.
29.
BeggCBMazumdarM. Operating characteristics of a rank correlation test for publication bias. Biometrics1994;50: 1088–101.
30.
DerSimonianRLairdN. Meta-analysis in clinical trials. Control Clin Trials1986;7: 177–88.
31.
SharpSJ. Meta-analysis regression. Stata Tech Bull1998;42: 16–22.
32.
ThompsonSGSharpSJ. Explaining heterogeneity in meta-analysis: A comparison of methods. Stat Med1999;18: 2693–708.
33.
HallasJHaghfeltTGramLFGrodumEDamsboN. Drug-related admissions to a cardiology department; frequency and avoidability. J Intern Med1990;228: 379–84.
34.
HallasJJensenKBGrodumEDamsboNGramLF. Drug-related admissions to a department of medical gastroenterology. The role of self-medicated and prescribed drugs. Scand J Gastroenterol1991;26: 174–80.
35.
HallasJWormJBeck-NielsenJGramLFGrodumEDamsboN. Drug-related events and drug utilization in patients admitted to a geriatric hospital department. Dan Med Bull1991;38: 417–20.
36.
TafreshiMJMelbyMJKabackKRNordTC. Medication-related visits to the emergency department: A prospective study. Ann Pharmacother1999;33: 1252–7.
37.
DennehyCEKishiDTLouieC. Drug-related illness in emergency department patients. Am J Health Syst Pharm1996;53: 1422–6.
EinarsonTR. Drug-related hospital admissions. Ann Pharmacother1993;27: 832–40.
40.
LazarouJPomeranzBHCoreyPN. Incidence of adverse drug reactions in hospitalized patients. JAMA1998;279: 1200–5.
41.
LeapeLLLawthersAGBrennanTAJohnsonWG. Preventing medical injury. Qual Rev Bull1993;19: 144–9.
42.
BatesDWCullenDJLairdNPetersenLASmallSDServiDIncidence of adverse drug events and potential adverse drug events: Implications for prevention. JAMA1995;274: 29–34.
43.
CullenDJSweitzerBJBatesDWBurdickEEdmondsonALeapeLL. Preventable adverse drug events in hospitalized patients: A comparative study of intensive care and general care units. Crit Care Med1997;25: 1289–97.
44.
BrennanTAHebertLELairdNMLawthersAThorpeKELeapeLLHospital characteristics associated with adverse events and substandard care. JAMA1991;265: 3265–9.
45.
WilsonRMRuncimanWBGibberdRWHarrisonBTNewbyLHamiltonJD. The Quality in Australian Health Care Study. Med J Aust1995;163: 458–71.
46.
O'NeilACPetersenLACookEFBatesDWLeeTHBrennanTA. Physician reporting compared with medical-record review to identify adverse medical events. Ann Intern Med1993;119: 370–6.
47.
CullenDJBatesDWSmallSDCooperJBNemeskalARLeapeLL. The incident reporting system does not detect adverse drug events: A problem for quality improvement. Jt Comm J Qual Improv1995;21: 541–8.
48.
JhaAKKupermanGJTeichJMLeapeLLSheaBRittenbergEIdentifying adverse drug events. JAMA1998;5: 305–14.
49.
HiattHHBarnesBABrennanTALairdNMLawthersAGLeapeLLA study of medical injury and medical malpractice. N Engl J Med1989;321: 480–4.
50.
KarchFESmithCLKerznerBMazzulloJMLasagnaL. Commentary—adverse drug reactions—a matter of opinion. Clin Pharmacol Ther1976;19: 489–92.
51.
LeapeLLBrennanTALairdNLawthersAGLocalioARBarnesBAThe nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med1991;324: 377–84.
